Management of malignant glioma--quo vadis?


Autoria(s): Stupp, R.; Hottinger, A.F.
Data(s)

2008

Identificador

https://serval.unil.ch/notice/serval:BIB_1457A298DB74

info:pmid:18547969

doi:10.1159/000134024

pmid:18547969

isiid:000256623000002

Idioma(s)

eng

Fonte

Onkologie316300-302

Palavras-Chave #Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemotherapy, Adjuvant; Dacarbazine; Glioma; Humans; Treatment Outcome
Tipo

info:eu-repo/semantics/article

article